Effect of erythropoiesis-stimulating agents on the progression of chronic kidney disease: a retrospective study
Not Applicable
- Conditions
- Chronic kidney disease patients with renal anemia
- Registration Number
- JPRN-UMIN000013311
- Lead Sponsor
- Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences, Kyushu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with apparent hemorrhagic lesion 2. Patients with hematologic disease (e.g. leukemia, malignant lymphoma, myelodysplastic syndrome, aplastic anemia) 3. Patients with apparent chronic inflammation (e.g. rheumatoid arthritis, inflammatory bowel disease) 4. Patients with complication of malignant tumor
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in the deterioration rate of estimated glomerular filtration rate (eGFR) after administration of ESA
- Secondary Outcome Measures
Name Time Method